Extrapyramidal Symptoms in Neuroleptic Recipients
- 1 January 1990
- book chapter
- Published by Springer Nature
- Vol. 29, 71-82
- https://doi.org/10.1007/978-3-0348-7292-8_7
Abstract
Adverse drug reactions (ADRs) in psychiatric therapy were continuously assessed in the AMUP study (AMUP = Arzneimittelüberwachung in der Psychiatrie (drug surveillance in psychiatry] conducted at two psychiatric university departments in the F.R.G. The Intensive Drug Monitoring (IDM) method was used to monitor 1107 patients, 754 of whom received neuroleptics (NLs). As is the rule in clinical psychiatric practice, polypharmacy was frequent, with combinations of two neuroleptics and combinations of a neuroleptic and an antiparkinson drug ranking first and second, respectively. Extrapyramidal motor symptoms (EPMS) were observed in 35% of the NL patients. In most cases they required a change in medication, usually addition of an antiparkinson drug. In about one quarter of all EPMS cases, withdrawal of the imputed NL was necessary. Parkinsonism was the most frequent single symptom, followed by acute dystonia and akathisia. Differences in EPMS rates between the two most frequently used neuroleptics, haloperidol, a high-potency butyrophenone, and perazine, a medium-potency phenothiazine, were distinct. EPMS were observed with haloperidol in 56% and attributed to haloperidol alone in 92% of these cases. With perazine, an EMPS occurred at a rate of only 14%, and in 37% of the cases EMPS were attributable to perazine in combination with other NLs. Age, sex, diagnosis and dosage of administered NLs were closely interrelated. For instance, NL patients over 60 years of age were almost exclusively female, the majority of them being endogenous depressives, whereas in younger patients the diagnosis of schizophrenia prevailed. Therefore, analysis of potential risk factors for development of EPMS must simultaneously include diagnosis, sex and age as well as concomitant physical disease, duration and dosage of all drugs administered before development of EPMS. However, the small case numbers in some subgroups, as we found them in this study based on everyday clinical practice, will probably be a limiting factor in such multivariate analyses.Keywords
This publication has 12 references indexed in Scilit:
- A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospitalAmerican Journal of Psychiatry, 1988
- Tardive dyskinesiaActa Psychiatrica Scandinavica, 1988
- Frequency and presentation of neuroleptic malignant syndrome: a prospective studyAmerican Journal of Psychiatry, 1987
- Neuroleptic Malignant SyndromeNew England Journal of Medicine, 1985
- Adverse drug reactionsActa Psychiatrica Scandinavica, 1984
- Drug-induced dystoniaAmerican Journal of Psychiatry, 1975
- An Adverse Reaction Unit: Results and FunctionsAmerican Journal of Psychiatry, 1971
- Epidemiological Studies of Adverse Drug ReactionsAmerican Journal of Public Health and the Nations Health, 1965
- A Survey of Drug-Induced Extrapyramidal ReactionsJAMA, 1961
- Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapyPsychopharmacology, 1960